Immune-mediated attack in relapsed Hodgkin's lymphoma

被引：3

作者：

Corradini, P ^{[1
]}

Farina, L

机构：

[1] Univ Milan, Ist Nazl Studio & Cura Tumori, Dept Haematol, Milan, Italy

[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA

来源：

LANCET | 2005年 / 365卷 / 9475期

关键词：

D O I：

10.1016/S0140-6736(05)66636-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1906 / 1908

页数：3

共 11 条

[1] Long-term results of blood and marrow transplantation for Hodgkin's lymphoma [J].

Akpek, G ;

Ambinder, RF ;

Piantadosi, S ;

Abrams, RA ;

Brodsky, RA ;

Vogelsang, GB ;

Zahurak, ML ;

Fuller, D ;

Miller, CB ;

Noga, SJ ;

Fuchs, E ;

Flinn, IW ;

O'Donnell, P ;

Seifter, EJ ;

Mann, RB ;

Jones, RJ .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (23) :4314-4321

[2] Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+cell dose, GVHD and disease response [J].

Anderlini, P ;

Acholonu, SA ;

Okoroji, GJ ;

Andersson, BS ;

Couriel, DR ;

De Lima, MJ ;

Donato, ML ;

Khouri, IF ;

Giralt, SA ;

Ueno, NT ;

Champlin, RE .

BONE MARROW TRANSPLANTATION, 2004, 34 (06) :511-514

[3] ALLOGENEIC, SYNGENEIC, AND AUTOLOGOUS MARROW TRANSPLANTATION FOR HODGKINS-DISEASE - THE 21-YEAR SEATTLE EXPERIENCE [J].

ANDERSON, JE ;

LITZOW, MR ;

APPELBAUM, FR ;

SCHOCH, G ;

FISHER, LD ;

BUCKNER, CD ;

PETERSEN, FB ;

CRAWFORD, SW ;

PRESS, OW ;

SANDERS, JE ;

BENSINGER, WI ;

MARTIN, PJ ;

STORB, R ;

SULLIVAN, KM ;

HANSEN, JA ;

THOMAS, ED .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (12) :2342-2350

[4] Reduced-intensity conditioning (RIC) followed by allogeneic transplantation in relapsed lymphomas: Evidence for Graft-Versus-Lymphoma effect in low and high grade histologies, but not in Hodgkin disease [J].

Corradini, P ;

Dodero, A ;

Bregni, M ;

Olivieri, A ;

Farina, L ;

Rizzo, E ;

Milni, R ;

Scime, R ;

Rambaldi, A ;

Bonifazi, F ;

Patriarca, F ;

Locasciulli, A ;

Bacigalupo, A ;

Gianni, AM ;

Tarella, C .

BLOOD, 2004, 104 (11) :230A-231A

[5] THE ANTIGEN-PRESENTING CELL-FUNCTION OF REED-STERNBERG CELLS [J].

DELABIE, J ;

CHAN, WC ;

WEISENBURGER, DD ;

DEWOLFPEETERS, C .

LEUKEMIA & LYMPHOMA, 1995, 18 (1-2) :35-40

[6]

DREGER P, 2000, BONE MARROW TRANS S1, V25, pS173

[7] Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease [J].

Gajewski, JL ;

Phillips, GL ;

Sobocinski, KA ;

Armitage, JO ;

Gale, RP ;

Champlin, RE ;

Herzig, RH ;

Hurd, DD ;

Jagannath, S ;

Klein, JP ;

Lazarus, HM ;

McCarthy, PL ;

Pavlovsky, S ;

Petersen, FB ;

Rowlings, PA ;

Russell, JA ;

Silver, SM ;

Vose, JM ;

Wiernik, PH ;

Bortin, MM ;

Horowitz, MM .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :572-578

[8] Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma [J].

Marshall, NA ;

Christie, LE ;

Munro, LR ;

Culligan, DJ ;

Johnston, PW ;

Barker, RN ;

Vickers, MA .

BLOOD, 2004, 103 (05) :1755-1762

[9] Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease [J].

Milpied, N ;

Fielding, AK ;

Pearce, RM ;

Ernst, P ;

Goldstone, AH .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1291-1296

[10] Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies [J].

Porter, DL ;

Connors, JM ;

Van Deerlin, VMD ;

Duffy, KM ;

McGarigle, C ;

Saidman, SL ;

Leonard, DGB ;

Antin, JH .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1234-1243

← 1 2 →